Interstitial Lung Disease: A Review.
Maher TM.
JAMA. 2024 May 21;331(19):1655-1665. doi: 10.1001/jama.2024.3669.
Management of interstitial lung disease associated with connective tissue disease.
Mathai SC, Danoff SK.
BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819.
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease.
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM.
Eur Respir J. 2026 Jan 22;67(1):2402533. doi: 10.1183/13993003.02533-2024. Print 2026 Jan.
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG).
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM.
Ann Rheum Dis. 2026 Jan;85(1):22-60. doi: 10.1016/j.ard.2025.08.021. Epub 2025 Sep 4.
Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers.
Cerro Chiang G, Parimon T.
Int J Mol Sci. 2023 Jan 26;24(3):2405. doi: 10.3390/ijms24032405.
Connective tissue disease-associated interstitial lung disease.
Storrer KM, Müller CS, Pessoa MCA, Pereira CAC.
J Bras Pneumol. 2024 Mar 22;50(1):e20230132. doi: 10.36416/1806-3756/e20230132. eCollection 2024.
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial.
Maher TM, Tudor VA, Saunders P, Gibbons MA, Fletcher SV, Denton CP, Hoyles RK, Parfrey H, Renzoni EA, Kokosi M, Wells AU, Ashby D, Szigeti M, Molyneaux PL; RECITAL Investigators.
Lancet Respir Med. 2023 Jan;11(1):45-54. doi: 10.1016/S2213-2600(22)00359-9. Epub 2022 Nov 11.
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).
Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, Bouros D, Hoffmann-Vold AM, Crestani B, Matteson EL.
Ann Rheum Dis. 2021 Feb;80(2):143-150. doi: 10.1136/annrheumdis-2020-217230. Epub 2020 Oct 9.
Interstitial lung disease in connective tissue disorders.
Fischer A, du Bois R.
Lancet. 2012 Aug 18;380(9842):689-98. doi: 10.1016/S0140-6736(12)61079-4.
Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment.
Jeganathan N, Sathananthan M.
Lung. 2020 Oct;198(5):735-759. doi: 10.1007/s00408-020-00383-w. Epub 2020 Aug 11.
